Single-cell transcriptional mapping reveals genetic and non-genetic determinants of aberrant differentiation in AML
Andy G.X. ZengiD, Ilaria IacobucciiD, Sayyam ShahiD, Amanda MitchelliD, Gordon WongiD, Suraj BansaliD, David CheniD, Qingsong GaoiD, Hyerin KimiD, James A. KennedyiD, Andrea ArrudaiD, Mark D. MindeniD, Torsten HaferlachiD, Charles G. MullighaniD, John E. DickiD
Abstract
In acute myeloid leukemia (AML), genetic mutations distort hematopoietic differentiation, resulting in the accumulation of leukemic blasts. Yet, it remains unclear how these mutations intersect with cellular origins and whether they converge upon similar differentiation patterns. Single-cell RNA sequencing (scRNA-seq) has enabled high-resolution mapping of the relationship between leukemia and normal cell states, yet this application is hampered by imprecise reference maps of normal hematopoiesis and small sample sizes among patient cohorts. As a first step we constructed a reference atlas of human bone marrow hematopoiesis from 263,519 single-cell transcriptomes spanning 55 cellular states, that was benchmarked against independent datasets of immunophenotypically pure hematopoietic stem and progenitor cells. Using this reference atlas, we mapped over 1.2 million single-cell transcriptomes spanning 318 AML, mixed phenotype acute leukemia (MPAL), and acute erythroid leukemia (AEL) samples. This large-scale analysis, together with systematic mapping of genotype-to-phenotype associations between driver mutations and differentiation landscapes, revealed convergence of diverse genetic alterations on twelve recurrent patterns of aberrant differentiation in AML. This included unconventional lymphoid and erythroid priming linked to RUNX1 and TP53 mutations, respectively. We also identified non-genetic determinants of AML differentiation such as two subgroups of KMT2A-rearranged AML that differ in the identity of their leukemic stem cells (LSCs), likely reflecting distinct cellular origins. Furthermore, distinct LSC-driven hierarchies can co-exist within individual patients, providing insights into AML evolution. Together, precise mapping of normal and malignant cell states provides a framework for advancing the study and disease classification of hematologic malignancies thereby informing therapy development.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Clonally resolved single-cell multi-omics identifies routes of cellular differentiation in acute myeloid leukemia
S. Beneyto-Calabuig, A. K. Ludwig, … L. Velten·bioRxiv·Aug 29, 2022
- Mutation detection in thousands of acute myeloid leukemia cells using single cell RNA-sequencing
Allegra A. Petti, Stephen R. Williams, … Timothy J. Ley·bioRxiv·Oct 17, 2018
- Identification of leukemic and pre-leukemic stem cells by clonal tracking from single-cell transcriptomics
Lars Velten, Benjamin A. Story, … Lars Michael Steinmetz·Nature CommunicationsPeer-reviewed·Mar 1, 2021
- Integrated decoding hematopoiesis and leukemogenesis at single-cell resolution and its clinical implication
Pengfei Qin, Yakun Pang, … Wenfei Jin·Cell DiscoveryPeer-reviewed·Jan 5, 2021
- Single Cell RNA Sequencing Driven Characterization of Pediatric Mixed Phenotype Acute Leukemia
Hope Mumme, Sunil S. Raikar, … Manoj Bhasin·bioRxiv·Jul 7, 2022
- Mining single-cell transcriptomic data reveals distinct T-cell population in pediatric B-ALL and AML at diagnosis
Liqing Tian, Stephen M Gottschalk·Blood AdvancesPeer-reviewed·Apr 14, 2026